RATIOGRASTIM

This brand name is authorized in Croatia, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Poland.

Active ingredients

The drug RATIOGRASTIM contains one active pharmaceutical ingredient (API):

1	Filgrastim UNII PVI5M0M1GW - FILGRASTIM
	Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.
	Read more about Filgrastim

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RATIOGRASTIM Solution for injection or infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AA02	Filgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06553013, 06553036, 11072066, 11072103, 11178652, 11178669, 12391307, 12412699, 12467890, 12475553, 12561347, 12595978, 13232031, 13515616, 13580921, 13580938, 15395694, 15786472, 16082431, 16082448
EE	Ravimiamet	1373183, 1373194, 1373206, 1373217, 1373228, 1373239
FI	Lääkealan turvallisuus- ja kehittämiskeskus	091592, 091604
FR	Base de données publique des médicaments	62542883, 63213271
IE	Health Products Regulatory Authority	88744, 88745
IT	Agenzia del Farmaco	038734012, 038734024, 038734036, 038734048, 038734051, 038734063, 038734075, 038734087, 038734099, 038734101, 038734113, 038734125
LT	Valstybinė vaistų kontrolės tarnyba	1034011, 1034012, 1034013, 1034014, 1034015, 1034016, 1034017, 1034018, 1064253, 1064254, 1064255, 1064256
PL	Rejestru Produktów Leczniczych	100081863, 100166565